The U.S. Food and Drug Administration expanded the emergency use authorization of Regeneron Pharmaceuticals Inc.’s Covid-19 antibody cocktail, enabling the combo therapy’s use as a preventive treatment for the illness in certain people.
If you are not happy with the results below please do another search
50 search results for:
The U.S. Securities and Exchange Commission halted registrations of U.S. initial public offerings (IPOs) by Chinese companies.
The world is at risk of losing hard-won gains in fighting Covid-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on July 30.
Gilead Sciences will open the doors to the company’s new operations site in North Raleigh, N.C., as part of a business services center expansion. Gilead’s second-quarter 2021 product sales increased 21 percent year-over-year, primarily driven by the Covid-19 antiviral treatment Veklury (remdesivir).
The U.S. Food and Drug Administration rejected Ardelyx Inc.’s chronic kidney disease drug tenapanor by issuing a Complete Response Letter.
Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca’s shot revealed no serious side effects and no subsequent cases of coronavirus among volunteers, the Russian Direct Investment Fund (RDIF) said on July 30.
President Joe Biden on July 29 urged local governments to pay people to get vaccinated against Covid-19, and set new rules requiring federal workers to provide proof of vaccination or face regular testing, mask mandates and travel restrictions.
Biogen Inc. and partner Eisai Co. Ltd. on July 29 revealed the design of an upcoming study of their controversial Alzheimer’s treatment, Aduhelm.
The U.S. Food and Drug Administration approved GlaxoSmithKline plc’s Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5, as a treatment for patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Three pharmaceutical and biotechnology companies announced the recent success of their respective funding rounds to support future efforts.